PF-07872412
Sponsors
Pfizer Inc.
Conditions
Pneumoccoccal Immunisation
Phase 3
C4931007 - A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS
Not yet recruitingCTIS2025-523447-35-02
Target: 425Updated: 2026-08-18
C4931004 - A Phase 3, Randomized Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Catch-Up Vaccination Regimen of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Children and Adolescents
Not yet recruitingCTIS2025-523445-10-00
Target: 480Updated: 2026-09-28